Stearoyl-CoA desaturase activity is elevated by the suppression of its degradation by cloribric acid in the liver of rats

被引:13
作者
Toyama, Tomoaki
Kudo, Naomi
Mitsumoto, Atsushi
Hibino, Yasuhide
Tsuda, Tadashi
Kawashima, Yoichi
机构
[1] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan
[2] Josai Int Univ, Fac Pharmaceut Sci, Chiba 2838555, Japan
关键词
stearoyl-CoA desaturase; protein degradation; palmitoyl-CoA chain elongase; clofibric acid;
D O I
10.1254/jphs.FP0061124
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A mechanism by which fibrates control stearoyl-CoA desaturase (SCD) in the liver was studied. Treatment of rats with 2-(4-chlorophenoxy)-2-methylpropionle acid (clofibric acid) or feeding of a fat-free diet markedly elevated hepatic activity of SCD. Both the treatment with clofibric acid and the feeding of the fat-free diet caused an increase in the steady-state level of SCD1 mRNA and enhanced transcriptional rate. The half-lives of SCD for control rats, rats treated with clofibric acid rats, and rats fed the fat-free diet were estimated to be 2.0, 3.9, and 1.9 h, respectively. Activity of palmitoyl-CoA chain elongase (PCE) was increased by both clofibric acid treatment and feeding of the fat-free diet as was observed with SCD. Steady-state level of rat fatty acid elongase 2 mRNA was increased by the treatment with clofibric acid or feeding of fat-free diet, although the transcriptional rate was not altered. Different from SCD, PCE was highly stable and its half-life was not changed by either clofibric acid or fat-free diet. These results strongly suggest that the decreased degradation of SCD is responsible for the increase in its activity in addition to increased transcription of SCD1 in the rats treated with clofibric acid.
引用
收藏
页码:383 / 390
页数:8
相关论文
共 37 条
  • [1] THE FATTY-ACID CHAIN ELONGATION SYSTEM OF MAMMALIAN ENDOPLASMIC-RETICULUM
    CINTI, DL
    COOK, L
    NAGI, MN
    SUNEJA, SK
    [J]. PROGRESS IN LIPID RESEARCH, 1992, 31 (01) : 1 - 51
  • [2] Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss
    Cohen, P
    Miyazaki, M
    Socci, ND
    Hagge-Greenberg, A
    Liedtke, W
    Soukas, AA
    Sharma, R
    Hudgins, LC
    Ntambi, JM
    Friedman, JM
    [J]. SCIENCE, 2002, 297 (5579) : 240 - 243
  • [3] Peroxisome proliferator-activated receptors: Nuclear control of metabolism
    Desvergne, B
    Wahli, W
    [J]. ENDOCRINE REVIEWS, 1999, 20 (05) : 649 - 688
  • [4] Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats
    Falvella, FS
    Pascale, RM
    Gariboldi, M
    Manenti, G
    De Miglio, MR
    Simile, MM
    Dragani, TA
    Feo, F
    [J]. CARCINOGENESIS, 2002, 23 (11) : 1933 - 1936
  • [5] Fruchart JC, 1998, AM J CARDIOL, V81, P912
  • [6] TISSUE-SPECIFIC INVITRO TRANSCRIPTION FROM THE MOUSE ALBUMIN PROMOTER
    GORSKI, K
    CARNEIRO, M
    SCHIBLER, U
    [J]. CELL, 1986, 47 (05) : 767 - 776
  • [7] A plasminogen-like protein selectively degrades stearoyl-CoA desaturase in liver microsomes
    Heinemann, FS
    Korza, G
    Ozols, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) : 42966 - 42975
  • [8] Stearoyl-CoA desaturase, a short-lived protein of endoplasmic reticulum with multiple control mechanisms
    Heinemann, FS
    Ozols, J
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2003, 68 (02): : 123 - 133
  • [9] Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor a in HepG2 cells
    Hsu, MH
    Savas, V
    Griffin, KJ
    Johnson, EF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) : 27950 - 27958
  • [10] Ichihara K., 1990, STAT BIOSCIENCE PRAC